Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Chemed Corporation (CHE : NYSE)

• Company Description    Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. Number of Employees: 15,811

• Price / Volume Information    Yesterday's Closing Price: $421.11 Daily Weekly Monthly 20 Day Moving Average: 237,937 shares Shares Outstanding: 14.61 (millions) Market Capitalization: $6,154.39 (millions) Beta: 0.49 52 Week High: $583.96 52 Week Low: $365.21 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 14.25% 1.55% 12 Week -1.41% -4.52% Year To Date -1.58% -5.97%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 255 EAST FIFTH STREET SUITE 2600 - CINCINNATI,OH 45202 USA ph: 513-762-6690 fax: 513-762-6590 None http://www.chemed.com

• General Corporate Information    Officers Kevin J. McNamara - Chief Executive Officer; President and Director Michael D. Witzeman - Executive Vice President; Chief Financial Officer; Ron DeLyons - Director Patrick P. Grace - Director Christopher J. Heaney - Director Peer Information Chemed Corporation (CMTI) Chemed Corporation (CMWLQ) Chemed Corporation (AHG.) Chemed Corporation (ROIX) Chemed Corporation (M.DCE) Chemed Corporation (DHSM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-OUTP/HM CRE Sector: Medical CUSIP: 16359R103 SIC: 8082 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 14.61 Most Recent Split Date: 5.00 (2.00:1) Beta: 0.49 Market Capitalization: $6,154.39 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.57% Current Fiscal Quarter EPS Consensus Estimate: $4.98 Indicated Annual Dividend: $2.40 Current Fiscal Year EPS Consensus Estimate: $21.92 Payout Ratio: 0.12 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.04 Estmated Long-Term EPS Growth Rate: 11.52% Last Dividend Paid: 02/23/2026 - $0.60 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: 19.21 Trailing 12 Months: 21.39 PEG Ratio: 1.67 Price Ratios Price/Book: 7.26 Price/Cash Flow: 17.07 Price / Sales: 2.42 EPS Growth vs. Year Ago Period: -0.59% vs. Previous Quarter: -14.19% Sales Growth vs. Year Ago Period: 1.63% vs. Previous Quarter: 2.84% ROE 03/31/26 - 27.18 12/31/25 - 25.66 09/30/25 - 25.89 ROA 03/31/26 - 17.38 12/31/25 - 17.24 09/30/25 - 17.59 Current Ratio 03/31/26 - 0.85 12/31/25 - 1.05 09/30/25 - 1.35 Quick Ratio 03/31/26 - 0.83 12/31/25 - 1.03 09/30/25 - 1.33 Operating Margin 03/31/26 - 10.98 12/31/25 - 11.25 09/30/25 - 11.70 Net Margin 03/31/26 - 10.23 12/31/25 - 10.48 09/30/25 - 11.02 Pre-Tax Margin 03/31/26 - 13.73 12/31/25 - 14.06 09/30/25 - 14.64 Book Value 03/31/26 - 58.02 12/31/25 - 69.15 09/30/25 - 76.01 Inventory Turnover 03/31/26 - 213.84 12/31/25 - 208.66 09/30/25 - 203.60 Debt-to-Equity 03/31/26 - 0.11 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 9.71 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©